Progress: Procedure completed
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | CONT | CZARNECKI Ryszard ( ECR) | CHRISTOFOROU Lefteris ( EPP), RÓNAI Sándor ( S&D), CSEH Katalin ( Renew), EICKHOUT Bas ( Verts/ALE), OMARJEE Younous ( GUE/NGL) |
Committee Opinion | ENVI | CANFIN Pascal ( Renew) |
Lead committee dossier:
Subjects
Events
The European Parliament decided by 614 votes to 48, with 36 abstentions, to grant discharge to the Director of the European Centre for Disease Prevention and Control in respect of the implementation of the Centre's budget for the financial year 2019 and to approve the closure of the accounts for that year.
Noting that the Court of Auditors stated that it had obtained reasonable assurance that the Authority's annual accounts for the financial year 2019 were reliable and that the underlying transactions were legal and regular, Parliament adopted, by 603 votes to 86 with 2 abstentions, a resolution containing a series of recommendations which form an integral part of the discharge decision and which complement the general recommendations set out in the resolution on the performance, financial management and control of EU agencies.
Centre's financial statements
The Centre's final budget for 2019 was EUR 59 206 000, an increase of 2.03% compared to 2018.
Budgetary and financial management
Members welcomed the budget monitoring efforts during the 2019 financial year which resulted in a budget implementation rate of 99.23%, which represents an increase of 0.71% compared to the 2018 financial year. The execution rate for payment appropriations was 81.41%, which was a slight increase of 0.19% compared to the previous year.
Other observations
Members also made a number of observations concerning performance, staff policy, public procurement, conflicts of interest and internal controls.
In particular, they noted that:
- the key performance indicators (KPIs) have been revised for the 2021-2023 single programming document: 90.3% of the 2019 work programme activities has been implemented;
- the Centre shares best practice and collaborates regularly with other EU agencies and bodies, including the European Food Safety Authority, the European Medicines Agency and the European Monitoring Centre for Drugs and Drug Addiction;
- the Centre has provided effective support in priority policy areas of the EU and Member States and has demonstrated its ability to adapt successfully to policy developments. It received a positive assessment of the coherence of its actions and coordination with other relevant bodies;
- in 2019, the Centre responded to 34 formal scientific requests from the Commission (including 10 from Members) and published a total of 219 reports, including 24 rapid risk assessments on diseases;
- on 31 December 2019, the establishment plan was 95.56 % implemented, with 172 temporary agents appointed out of 180 temporary agents authorised under the Union budget; the gender balance is relatively good;
- the Centre should continue to develop a long-term human resources policy framework, which covers work-life balance, lifelong guidance and career development, gender balance, teleworking, geographical balance and the recruitment and integration of people with disabilities;
- the Centre has made efforts to create a 'green' working environment and has taken steps to reduce its carbon footprint and energy consumption and to implement a paperless workflow;
- the use of electronic procurement workflows has enabled 11 procurement procedures to be launched in 2019;
- the Centre should publish the declarations of interest and CVs of all Management Board and Advisory Forum members, and inform the discharge authority of the steps taken in this respect;
- further steps have been taken to disseminate the results of its research to the general public and to address the public through social media and other channels.
Documents
- Decision by Parliament: T9-0187/2021
- Debate in Parliament: Debate in Parliament
- Committee report tabled for plenary, single reading: A9-0104/2021
- Committee report tabled for plenary: A9-0104/2021
- Amendments tabled in committee: PE680.779
- Supplementary non-legislative basic document: 05793/2021
- Committee opinion: PE658.869
- Committee draft report: PE657.210
- Non-legislative basic document: COM(2020)0288
- Non-legislative basic document: EUR-Lex
- Non-legislative basic document published: COM(2020)0288
- Non-legislative basic document published: EUR-Lex
- Non-legislative basic document: COM(2020)0288 EUR-Lex
- Committee draft report: PE657.210
- Committee opinion: PE658.869
- Supplementary non-legislative basic document: 05793/2021
- Amendments tabled in committee: PE680.779
- Committee report tabled for plenary, single reading: A9-0104/2021
Votes
Décharge 2019 : Centre européen de prévention et de contrôle des maladies - 2019 discharge: European Centre for Disease Prevention and Control - Entlastung 2019: Europäisches Zentrum für die Prävention und die Kontrolle von Krankheiten - A9-0104/2021 - Ryszard Czarneck - Propositions de décision #
Décharge 2019 : Centre européen de prévention et de contrôle des maladies - 2019 discharge: European Centre for Disease Prevention and Control - Entlastung 2019: Europäisches Zentrum für die Prävention und die Kontrolle von Krankheiten - A9-0104/2021 - Ryszard Czarnecki - Am 1/1 #
A9-0104/2021 - Ryszard Czarnecki - Am 1/2 #
Décharge 2019 : Centre européen de prévention et de contrôle des maladies - 2019 discharge: European Centre for Disease Prevention and Control - Entlastung 2019: Europäisches Zentrum für die Prävention und die Kontrolle von Krankheiten - A9-0104/2021 - Proposition de résolution #
Amendments | Dossier |
5 |
2020/2163(DEC)
2020/12/17
ENVI
5 amendments...
Amendment 1 #
Draft opinion Paragraph 5 5. Reiterates its concern that only 89 % of management board members and 81 % of advisory forum members submitted the required annual declarations of interest in 2019; notes that these figures are respectively 7 and 8 percentage points lower than in 2018; recalls that independence and transparency are crucial given the important work of the Centre; calls for a mechanism to ensure that all outstanding and future declarations of interest are submitted without delay, and calls on the Centre to consider not allowing members to take up their roles before this crucial information is provided and checked;
Amendment 2 #
Draft opinion Paragraph 5 5. Reiterates its concern that only 89 % of management board members and 81 % of advisory forum members submitted the required annual declarations of interest in 2019; notes that these figures are respectively 7 and 8 percentage points lower than in 2018; welcomes the introduction of penalties, whereby, for non-submission of declarations of interest by management board and advisory forum members, a restricted access to meeting documents and the extranet is implemented and applied from early 2020;
Amendment 3 #
Draft opinion Paragraph 5 5.
Amendment 4 #
Draft opinion Paragraph 6 6. Welcomes the positive outcome of the Centre's third external evaluation, which found that the Centre’s activities and outputs were relevant to stakeholders, and were of high scientific quality; underlines, however, that the COVID-19 crisis has
Amendment 5 #
Draft opinion Paragraph 8 8. Stresses that the Centre should continue promoting cooperation with other Union agencies and international organisations, and fostering dialogue with stakeholders and citizens; welcomes the launch of two new programmes in 2019: e-health and digital technologies and foresight;
source: 660.423
|
History
(these mark the time of scraping, not the official date of the change)
events/0/date |
Old
2020-06-29T00:00:00New
2020-06-28T00:00:00 |
events/6 |
|
procedure/final |
|
procedure/stage_reached |
Old
Procedure completed, awaiting publication in Official JournalNew
Procedure completed |
events/4/docs |
|
docs/6 |
|
events/5/summary |
|
docs/6 |
|
events/5 |
|
procedure/stage_reached |
Old
Awaiting Parliament's voteNew
Procedure completed, awaiting publication in Official Journal |
events/1/body |
EP
|
events/2/body |
EP
|
events/3/body |
EP
|
docs/5 |
|
events/1 |
|
events/1 |
|
events/2 |
|
events/2 |
|
events/3/docs |
|
events/4 |
|
forecasts |
|
docs/1/docs/0/url |
Old
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE657.210New
https://www.europarl.europa.eu/doceo/document/CONT-PR-657210_EN.html |
docs/2/docs/0/url |
Old
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE658.869&secondRef=02New
https://www.europarl.europa.eu/doceo/document/ENVI-AD-658869_EN.html |
docs/4/docs/0/url |
Old
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE680.779New
https://www.europarl.europa.eu/doceo/document/CONT-AM-680779_EN.html |
events/3 |
|
procedure/stage_reached |
Old
Awaiting committee decisionNew
Awaiting Parliament's vote |
committees/0 |
|
committees/0 |
|
docs/2/docs/0/url |
Old
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE658.869New
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE658.869&secondRef=02 |
events/2 |
|
forecasts |
|
procedure/Other legal basis |
Rules of Procedure EP 159
|
docs/2/docs/0/url |
Old
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE658.869&secondRef=02New
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE658.869 |
docs/2/docs/0/url |
Old
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE658.869New
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE658.869&secondRef=02 |
docs/4/docs/0/url |
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE680.779
|
docs/4/date |
Old
2021-03-03T00:00:00New
2021-03-04T00:00:00 |
docs/4/date |
Old
2021-03-01T00:00:00New
2021-03-03T00:00:00 |
committees/0 |
|
committees/0 |
|
commission |
|
docs/2/docs/0/url |
Old
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE658.869&secondRef=02New
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE658.869 |
docs/4 |
|
committees/0 |
|
committees/0 |
|
docs/3 |
|
committees/0 |
|
committees/0 |
|
docs/2/docs/0/url |
Old
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE658.869New
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE658.869&secondRef=02 |
committees/0 |
|
committees/0 |
|
committees/1/rapporteur/0/mepref |
96711
|
docs/1 |
|
docs/2 |
|
committees/0 |
|
committees/0 |
|
committees/1/rapporteur/0/mepref |
96711
|
committees/1/rapporteur |
|
events/1 |
|
procedure/dossier_of_the_committee |
|
procedure/stage_reached |
Old
Preparatory phase in ParliamentNew
Awaiting committee decision |
committees/0/rapporteur |
|
committees/0 |
|
committees/0 |
|
committees/0/shadows |
|